We have previously shown that treatment-naïve JDM patient NK cells are highly activated and proliferative as measured by CD69 and Ki67, respectively (20), and our current RNAseq analysis confirms this finding. This evidence concerns the gene MKI67 and juvenile dermatomyositis.